STOCKHOLM, SWEDEN November 4, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company, Modus Therapeutics, has received regulatory approval to initiate the ...

Anemia of chronic disease is anemia caused by inflammation from a long-term or chronic illness. It is also called anemia of inflammation. People with anemia of chronic disease may have normal or even ...

Studies show patients with chronic kidney disease (CKD) and COVID-19 are at increased risk for an intensive care unit stay and early death. Anemia is an extra risk factor.

The proposed trial aimed to study the use of vadadustat to treat anemia in patients with late-stage chronic kidney disease not on dialysis. The treatment is already approved for such patients who have ...

Akebia shares decline after the company ends plans for its VALOR trial, citing FDA feedback and high costs tied to expanding ...

Former New York Jets star Nick Mangold has died following complications from chronic kidney disease aged 41. The football ...

Sickle cell disease (SCD) is a group of inherited blood disorders characterised by a single point mutation in the β-globin ...

Expands access to much-needed iron therapy for millions of US patients Builds Sandoz portfolio of high-quality injectable iron therapies and sets stage for future launches Strengthens US supply of ...

Akebia Therapeutics (($AKBA)) announced an update on their ongoing clinical study. Akebia Therapeutics recently updated its clinical study titled ...

The iron deficiency anemia therapy market is propelled by the increasing ... The growing prevalence of chronic kidney disease ...

Shares of Akebia Therapeutics fell sharply premarket after it abandoned plans for a clinical trial of its anemia treatment in patients not on kidney dialysis following a meeting with the Food and Drug ...